These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21041915)

  • 1. HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania.
    Johannessen A; Holberg-Petersen M; Lövgaarden G; Naman E; Ormaasen V; Matee MI; Gundersen SG; Bruun JN
    Antivir Ther; 2010; 15(7):1003-9. PubMed ID: 21041915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania.
    Johannessen A; Garrido C; Zahonero N; Sandvik L; Naman E; Kivuyo SL; Kasubi MJ; Gundersen SG; Bruun JN; de Mendoza C
    Clin Infect Dis; 2009 Sep; 49(6):976-81. PubMed ID: 19663598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.
    Bertagnolio S; Parkin NT; Jordan M; Brooks J; García-Lerma JG
    AIDS Rev; 2010; 12(4):195-208. PubMed ID: 21179184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings.
    Johannessen A; Trøseid M; Calmy A
    J Antimicrob Chemother; 2009 Dec; 64(6):1126-9. PubMed ID: 19776036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dried blood spots versus plasma for the quantification of HIV-1 RNA using the manual (PCR-ELISA) amplicor monitor HIV-1 version 1.5 assay in Yaounde, Cameroon.
    Ikomey GM; Atashili J; Okomo-Assoumou MC; Mesembe M; Ndumbe PM
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):181-4. PubMed ID: 19357423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal.
    Kane CT; Ndiaye HD; Diallo S; Ndiaye I; Wade AS; Diaw PA; Gaye-Diallo A; Mboup S
    J Virol Methods; 2008 Mar; 148(1-2):291-5. PubMed ID: 18242718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic testing for HIV-1 drug resistance using dried blood samples.
    Lira R; Valdez-Salazar H; Vazquez-Rosales G; Rojas-Montes O; Ruiz-Tachiquin M; Torres-Ibarra R; Cano-Dominguez C; Maldonado-Rodríguez A; Gomez A; Muñoz O; Alvarez-Muñoz MT
    Arch Virol; 2010 Jul; 155(7):1117-25. PubMed ID: 20496089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay.
    Hallack R; Doherty LE; Wethers JA; Parker MM
    J Clin Virol; 2008 Apr; 41(4):283-7. PubMed ID: 18243787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance.
    Wei X; Youngpairoj AS; Garrido C; Zahonero N; Corral A; de Mendoza C; Heneine W; Johnson JA; Garcia-Lerma JG
    J Clin Virol; 2011 Feb; 50(2):148-52. PubMed ID: 21130027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy.
    Rottinghaus EK; Ugbena R; Diallo K; Bassey O; Azeez A; Devos J; Zhang G; Aberle-Grasse J; Nkengasong J; Yang C
    Clin Infect Dis; 2012 Apr; 54(8):1187-95. PubMed ID: 22412066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 drug resistance surveillance using dried whole blood spots.
    Bertagnolio S; Soto-Ramirez L; Pilon R; Rodriguez R; Viveros M; Fuentes L; Harrigan PR; Mo T; Sutherland D; Sandstrom P
    Antivir Ther; 2007; 12(1):107-13. PubMed ID: 17503754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping.
    Monleau M; Butel C; Delaporte E; Boillot F; Peeters M
    J Antimicrob Chemother; 2010 Aug; 65(8):1562-6. PubMed ID: 20542904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of HIV-1 RNA in dried blood and plasma spots.
    Reigadas S; Schrive MH; Aurillac-Lavignolle V; Fleury HJ
    J Virol Methods; 2009 Oct; 161(1):177-80. PubMed ID: 19523984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
    Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
    J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay.
    Andreotti M; Pirillo M; Guidotti G; Ceffa S; Paturzo G; Germano P; Luhanga R; Chimwaza D; Mancini MG; Marazzi MC; Vella S; Palombi L; Giuliano M
    J Clin Virol; 2010 Jan; 47(1):4-7. PubMed ID: 19962936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.
    Delaugerre C; Warszawski J; Chaix ML; Veber F; Macassa E; Buseyne F; Rouzioux C; Blanche S
    J Med Virol; 2007 Sep; 79(9):1261-9. PubMed ID: 17607781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p24 antigen detection on dried blood spots is a feasible and reliable test for infant HIV infection in rural Tanzania.
    Kivuyo SL; Johannessen A; Trøseid M; Kasubi MJ; Gundersen SG; Naman E; Mushi D; Ngowi BJ; Mfinanga GS; Bruun JN
    Int J STD AIDS; 2011 Dec; 22(12):719-21. PubMed ID: 22174052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine.
    Bocket L; Yazdanpanah Y; Ajana F; Gerard Y; Viget N; Goffard A; Alcaraz I; Wattré P; Mouton Y
    J Antimicrob Chemother; 2004 Jan; 53(1):89-94. PubMed ID: 14645320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.